Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer

Colorectal cancer with peritoneal metastases is currently treated by cytoreductive surgery and locoregional chemotherapeutics. This standard treatment is associated with high morbidity, mortality, and recurrence rate. To augment the existing therapy, we developed a liposome-based delivery system con...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Griffin Pauli, Po-Han Chao, Zhu Qin, Roland Böttger, Suen Ern Lee, Shyh-Dar Li
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2021-10-01
coleção:	Pharmaceutics
Assuntos:	liposomes drug delivery resiquimod peritoneal metastasis of cancer immunotherapy toll-like receptor agonist
Acesso em linha:	https://www.mdpi.com/1999-4923/13/10/1696
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!